Irbesartan in patients with atrial fibrillation

Salim Yusuf, Jeff S Healey, Janice Pogue, Susan Chrolavicius, Marcus Flather, Robert G Hart, Stefan H Hohnloser, Campbell D Joyner, Marc A Pfeffer, Stuart J Connolly, ACTIVE I Investigators, Keith Fox

Research output: Contribution to journalArticlepeer-review

Abstract

The risk of cardiovascular events among patients with atrial fibrillation is high. We evaluated whether irbesartan, an angiotensin-receptor blocker, would reduce this risk.
Original languageEnglish
Pages (from-to)928-38
Number of pages11
JournalNew England Journal of Medicine
Volume364
Issue number10
DOIs
Publication statusPublished - 2011

Fingerprint

Dive into the research topics of 'Irbesartan in patients with atrial fibrillation'. Together they form a unique fingerprint.

Cite this